212 related articles for article (PubMed ID: 23704325)
41. Quaking regulates Hnrnpa1 expression through its 3' UTR in oligodendrocyte precursor cells.
Zearfoss NR; Clingman CC; Farley BM; McCoig LM; Ryder SP
PLoS Genet; 2011 Jan; 7(1):e1001269. PubMed ID: 21253564
[TBL] [Abstract][Full Text] [Related]
42. RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element.
Bilodeau PS; Domsic JK; Mayeda A; Krainer AR; Stoltzfus CM
J Virol; 2001 Sep; 75(18):8487-97. PubMed ID: 11507194
[TBL] [Abstract][Full Text] [Related]
43. hnRNP A1 mediates the activation of the IRES-dependent SREBP-1a mRNA translation in response to endoplasmic reticulum stress.
Damiano F; Rochira A; Tocci R; Alemanno S; Gnoni A; Siculella L
Biochem J; 2013 Jan; 449(2):543-53. PubMed ID: 23106379
[TBL] [Abstract][Full Text] [Related]
44. A truncated hnRNP A1 isoform, lacking the RGG-box RNA binding domain, can efficiently regulate HIV-1 splicing and replication.
Jean-Philippe J; Paz S; Lu ML; Caputi M
Biochim Biophys Acta; 2014; 1839(4):251-8. PubMed ID: 24530421
[TBL] [Abstract][Full Text] [Related]
45. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
46. Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: from structural insights to post-transcriptional regulatory roles.
Bekenstein U; Soreq H
Mol Cell Neurosci; 2013 Sep; 56():436-46. PubMed ID: 23247072
[TBL] [Abstract][Full Text] [Related]
47. hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer.
Del Gatto-Konczak F; Olive M; Gesnel MC; Breathnach R
Mol Cell Biol; 1999 Jan; 19(1):251-60. PubMed ID: 9858549
[TBL] [Abstract][Full Text] [Related]
48. HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.
Guo R; Li Y; Ning J; Sun D; Lin L; Liu X
PLoS One; 2013; 8(4):e62729. PubMed ID: 23658645
[TBL] [Abstract][Full Text] [Related]
49. Combined use of MS2 and PP7 coat fusions shows that TIA-1 dominates hnRNP A1 for K-SAM exon splicing control.
Gesnel MC; Del Gatto-Konczak F; Breathnach R
J Biomed Biotechnol; 2009; 2009():104853. PubMed ID: 20130820
[TBL] [Abstract][Full Text] [Related]
50. Functional implications of the emergence of alternative splicing in hnRNP A/B transcripts.
Han SP; Kassahn KS; Skarshewski A; Ragan MA; Rothnagel JA; Smith R
RNA; 2010 Sep; 16(9):1760-8. PubMed ID: 20651029
[TBL] [Abstract][Full Text] [Related]
51. Heterogeneous nuclear ribonucleoproteins A1 and A2 modulate expression of Tid1 isoforms and EGFR signaling in non-small cell lung cancer.
Chen CY; Jan CI; Pi WC; Wang WL; Yang PC; Wang TH; Karni R; Wang TC
Oncotarget; 2016 Mar; 7(13):16760-72. PubMed ID: 26919236
[TBL] [Abstract][Full Text] [Related]
52. Antagonistic effects of the SRp30c protein and cryptic 5' splice sites on the alternative splicing of the apoptotic regulator Bcl-x.
Cloutier P; Toutant J; Shkreta L; Goekjian S; Revil T; Chabot B
J Biol Chem; 2008 Aug; 283(31):21315-24. PubMed ID: 18534987
[TBL] [Abstract][Full Text] [Related]
53. Heterogeneous nuclear ribonucleoprotein (hnRNP) K is a component of an intronic splicing enhancer complex that activates the splicing of the alternative exon 6A from chicken beta-tropomyosin pre-mRNA.
Expert-Bezançon A; Le Caer JP; Marie J
J Biol Chem; 2002 May; 277(19):16614-23. PubMed ID: 11867641
[TBL] [Abstract][Full Text] [Related]
54. Solution Structure of the HIV-1 Intron Splicing Silencer and Its Interactions with the UP1 Domain of Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A1.
Jain N; Morgan CE; Rife BD; Salemi M; Tolbert BS
J Biol Chem; 2016 Jan; 291(5):2331-44. PubMed ID: 26607354
[TBL] [Abstract][Full Text] [Related]
55. Crystal structure of human UP1, the domain of hnRNP A1 that contains two RNA-recognition motifs.
Xu RM; Jokhan L; Cheng X; Mayeda A; Krainer AR
Structure; 1997 Apr; 5(4):559-70. PubMed ID: 9115444
[TBL] [Abstract][Full Text] [Related]
56. Position-dependent effects of hnRNP A1/A2 in SMN1/2 exon7 splicing.
Qiu J; Qu R; Lin M; Xu J; Zhu Q; Zhang Z; Sun J
Biochim Biophys Acta Gene Regul Mech; 2022 Nov; 1865(8):194875. PubMed ID: 36208849
[TBL] [Abstract][Full Text] [Related]
57. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H
Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392
[TBL] [Abstract][Full Text] [Related]
58. Heterogeneous nuclear ribonucleoprotein G regulates splice site selection by binding to CC(A/C)-rich regions in pre-mRNA.
Heinrich B; Zhang Z; Raitskin O; Hiller M; Benderska N; Hartmann AM; Bracco L; Elliott D; Ben-Ari S; Soreq H; Sperling J; Sperling R; Stamm S
J Biol Chem; 2009 May; 284(21):14303-15. PubMed ID: 19282290
[TBL] [Abstract][Full Text] [Related]
59. Encoded Conformational Dynamics of the HIV Splice Site A3 Regulatory Locus: Implications for Differential Binding of hnRNP Splicing Auxiliary Factors.
Chiu LY; Emery A; Jain N; Sugarman A; Kendrick N; Luo L; Ford W; Swanstrom R; Tolbert BS
J Mol Biol; 2022 Sep; 434(18):167728. PubMed ID: 35870649
[TBL] [Abstract][Full Text] [Related]
60. The prevalent deep intronic c. 639+919 G>A GLA mutation causes pseudoexon activation and Fabry disease by abolishing the binding of hnRNPA1 and hnRNP A2/B1 to a splicing silencer.
Palhais B; Dembic M; Sabaratnam R; Nielsen KS; Doktor TK; Bruun GH; Andresen BS
Mol Genet Metab; 2016 Nov; 119(3):258-269. PubMed ID: 27595546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
